{ "items": [ "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Nocturnal temperature-controlled laminar airflow device for adults with severe allergic asthma: the LASER RCT.\n

\n \n \n \n \n\n \n \n \n

Kapoor M. et al, (2019), Health technology assessment (Winchester, England), 23, 1 - 140

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: Evidence from the MIST2 randomised controlled trial.\n

\n \n \n \n \n\n \n \n \n

Luengo-Fernandez R. et al, (2019), The European respiratory journal

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n \n
\n \n \n

\n Association of Late Functional Improvement With 5-Year Post-stroke Outcomes: A Population-based Cohort Study\n

\n \n \n \n \n\n \n \n \n

Ganesh A. et al, (2019), NEUROLOGY, 92

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Cost-effectiveness of digital surveillance clinics with optical coherence tomography versus hospital eye service follow-up for patients with screen-positive maculopathy.\n

\n \n \n \n \n\n \n \n \n

Leal J. et al, (2019), Eye (Lond), 33, 640 - 647

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n \n
\n \n \n

\n Association of Late Functional Improvement With 5-Year Post-stroke Outcomes: A Population-based Cohort Study\n

\n \n \n \n \n\n \n \n \n

Ganesh A. et al, (2019), STROKE, 50

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n DEMENTIA AND HOSPITAL ADMISSION POST-TIA AND STROKE: LONGITUDINAL POPULATION-BASED STUDY\n

\n \n \n \n \n\n \n \n \n

McColl AJ. et al, (2019), AGE AND AGEING, 48

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n \n
\n \n \n

\n Long-term Clinical and Health Economic Consequences of Worsened Post-stroke Status in Patients With Pre-morbid Disability\n

\n \n \n \n \n\n \n \n \n

Ganesh A. et al, (2019), STROKE, 50

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Ordinal vs dichotomous analyses of modified Rankin Scale, 5-year outcome, and cost of stroke.\n

\n \n \n \n \n\n \n \n \n

Ganesh A. et al, (2018), Neurology, 91, e1951 - e1960

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Long-Term Consequences of Worsened Poststroke Status in Patients With Premorbid Disability.\n

\n \n \n \n \n\n \n \n \n

Ganesh A. et al, (2018), Stroke, 49, 2430 - 2436

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n \n
\n \n \n

\n TEMPORAL TRENDS (2002-2012) IN LONG-TERM OUTCOME AND QUALITY-ADJUSTED LIFE-EXPECTANCY AFTER INCIDENT STROKE IN OXFORDSHIRE, UK: EVIDENCE OF IMPACT OF ACUTE STROKE CARE AT THE POPULATION-LEVEL\n

\n \n \n \n \n\n \n \n \n

Luengo-Fernandez R. et al, (2018), INTERNATIONAL JOURNAL OF STROKE, 13, 34 - 35

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Cost-effectiveness of cognitive behavioural therapy for sleep disorder added to usual care in patients with schizophrenia: the BEST study\n

\n \n \n \n \n\n \n \n \n

Tsiachristas A. et al, (2018), BJPsych Open

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n \n
\n \n \n

\n Long-term Consequences of Further Post-stroke Disability in Patients with Pre-morbid Disability: Potential for Acute Stroke Therapies\n

\n \n \n \n \n\n \n \n \n

Ganesh A. et al, (2018), NEUROLOGY, 90

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n \n
\n \n \n

\n Three-Month Modified Rankin Scale Score Predicts 5-Year Post-Stroke Dementia And Institutionalization Outcomes: A Population-Based Prospective Cohort Study\n

\n \n \n \n \n\n \n \n \n

Ganesh A. et al, (2018), STROKE, 49

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n \n
\n \n \n

\n Economic burden of CVD across the European Union: trends over the last decade\n

\n \n \n \n \n\n \n \n \n

Luengo-Fernandez R. et al, (2017), EUROPEAN HEART JOURNAL, 38, 994 - 994

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Time Course of Evolution of Disability and Cause-Specific Mortality After Ischemic Stroke: Implications for Trial Design.\n

\n \n \n \n \n\n \n \n \n

Ganesh A. et al, (2017), Journal of the American Heart Association, 6

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n \n
\n \n \n

\n Time-course of functional recovery after acute ischaemic stroke and its relationship to cause-specific mortality: Implications for follow-up of stroke trials\n

\n \n \n \n \n\n \n \n \n

Ganesh A. et al, (2017), NEUROLOGY, 88

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n \n
\n \n \n

\n One- month Modified Rankin Scale (mRS) Score Predicts Five-year Disability, Death, Quality-of-Life, and Healthcare Costs in Ischaemic Stroke: A Prospective Cohort Study\n

\n \n \n \n \n\n \n \n \n

Ganesh A. et al, (2017), STROKE, 48

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n \n
\n \n \n

\n European Cardiovascular Disease Statistics 2017\n

\n \n \n \n \n\n \n \n \n

Wilkins E et al, (2017), European Heart Network

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n
\n
\n \n \n

\n Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion.\n

\n \n \n \n \n\n \n \n \n

Olfert JA. et al, (2016), Respirology

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n", "\n\n
\n\n
\n\n \n\n
\n \n \n
\n \n
\n \n \n

\n Economic burden of malignant blood disorders across Europe: a population-based cost analysis.\n

\n \n \n \n \n\n \n \n \n

Burns R. et al, (2016), The Lancet. Haematology, 3, e362 - e370

\n \n \n \n

\n \n

\n \n \n
\n\n
\n\n
\n\n\n" ], "more": "\n\n \n \n Load More\n \n \n\n", "msg": "" }